Skip to main content

Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D)

Project description

Innovative treatment for autoimmune diabetes

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Coordinator

AHEAD THERAPEUTICS SL
Net EU contribution
€ 50 000,00
Address
Edifici Eureka Parc Recerca Uab Campus Uab S/n
08193 Cerdanyola Del Valles
Spain

See on map

Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00